Staff editor

Targeting gut microbiome for disease diagnosis and therapy

Francesco Peri, full professor at University of Milano-Bicocca, discussed the role of gut microbiome as new frontier for personalized medicine.

Pre-hypertension: from Biofarma Group a nutraceutical solution to counteract it

Tensred plus®: an innovative formula to combat pre-hypertension.

MASTERing food chain microbiomes – the webinar

Key outputs and innovations of direct relevance to food and agriculture from the H2020 funded MASTER project.

Human gut bacteria produce Th17-modulating bile acid metabolites

During MicrobiotaMI congress we discussed with Jun Huh, Associate Professor at Harvard University, about the research on microbiome.

Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert

This partnership aims to leverage Microba's advanced technology platform for measuring the human gut microbiome to discover novel biomarkers for pancreatic cancer detection. 

Gut microbiome affects tumor regression of oncolytic adenovirus-treated melanoma

Microbiomepost discussed with Lorella Tripodi, University Federico II of Naples, about the research she is working with her colleagues.

Ode to the people – Declaration of intent by SynBalance

10 principles summarizing SynBalance's belief about taking care of people’s health.

The most promising future application of microbiome science discussed at MicrobiotaMI congress

Microbiomepost discussed with Nicasio Mancini about the role of gut microbiome in immune response and in the antibiotic resistance.

MaaT Pharma Announces U.S. FDA Lifts Clinical Hold on Phase 3 Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease

This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology, which provides greater…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.